ORM-5029

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
BPS-82935-1	1 mg	-	-	-	3 - 8 business days*		3,072.00€
BPS-82935-2	5 mg	-	-	-	3 - 8 business days*		7,098.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

ORM-5029 is a first-in-class human epidermal growth factor receptor 2 (HER2)-targeted... more

Close menu

Product information "ORM-5029"

ORM-5029 is a first-in-class human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate (ADC) comprised of SMol006, a highly potent GSPT1 degrader, conjugated to Pertuzumab. ORM-5029 can be used for study of cancer1.

Keywords:	Anti-HER2, Anti-CD340, Anti-ERBB2, Anti-MLN 19, Anti-p185erbB2, EC=2.7.10.1, Anti-Proto-oncogene Neu, Anti-Proto-oncogene c-ErbB-2, Anti-Metastatic lymph node gene 19 protein, Anti-Receptor tyrosine-protein kinase erbB-2,
Supplier:	BPS Bioscience
Supplier-Nr:	82935

Properties

Application:	Cancer therapy target studies
Conjugate:	No
Species reactivity:	human
Format:	Solution

Database Information

KEGG ID :	K05083 \| Matching products
UniProt ID :	P04626 \| Matching products
Gene ID :	GeneID 2064 \| Matching products

Handling & Safety

Storage:	-80°C (protect from light)
Shipping:	-80°C (International: -80°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody 82935 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "ORM-5029"

Write a review